Related Experiment Video

Updated: Aug 25, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Cardiovascular disease: potential impact of stem cell therapy

David L Amrani1, Steven Port

  • 1Baxter Healthcare, RLT-12 Route 120 and Wilson Rd, Round Lake, IL 60073, USA. david_amrani@baxter.com

Expert Review of Cardiovascular Therapy
|March 20, 2004
PubMed

Insights

Hematopoietic stem cells (HSCs) show promise for treating cardiovascular disease by potentially regenerating damaged blood vessels and heart muscle. Clinical trials indicate effectiveness in acute myocardial infarction and limb ischemia, with ongoing research exploring mechanisms and further applications.

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Stem Cell Biology

Background:

  • Atherosclerotic vascular disease limits blood flow, causing tissue damage.
  • Myocardial infarction and limb ischemia result in irreversible loss of cardiac muscle and blood vessels.
  • Hematopoietic stem cells (HSCs) are being investigated for their potential to treat cardiovascular conditions.

Purpose of the Study:

  • To evaluate the effectiveness and safety of hematopoietic stem cells (HSCs) in treating acute myocardial infarction and limb ischemia.
  • To explore the mechanisms by which transplanted stem cells differentiate into vascular and cardiac cells.
  • To plan future clinical trials for chronic cardiovascular conditions using selected stem cell populations.

Main Methods:

  • Conducting clinical trials in patients with acute myocardial infarction and limb ischemia.
  • Utilizing hematopoietic stem cells (HSCs), including CD34+ and CD133+ cells, endothelial progenitor cells (EPCs), and mesenchymal stem cells.
  • Planning preclinical studies to investigate stem cell homing and differentiation.

Main Results:

  • Initial clinical studies demonstrated the potential effectiveness of HSC therapy for acute myocardial ischemia and limb ischemia.
  • HSCs have the capacity to differentiate into endothelial cells (as EPCs) and potentially cardiac muscle cells.
  • The safety and efficacy of HSCs in treating cardiovascular disease are under active investigation.

Conclusions:

  • Hematopoietic stem cell therapy presents a promising approach for treating cardiovascular diseases like myocardial infarction and limb ischemia.
  • Further research is needed to fully understand the mechanisms of stem cell differentiation and optimize therapeutic strategies.
  • Future clinical trials will assess a broader range of stem cell types and patient conditions, including chronic ischemia.

More Related Videos

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...